These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 25434769)

  • 1. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
    Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M
    J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
    Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
    Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
    Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
    ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
    Foster DJ; Brown CR; Shaikh S; Trapp C; Schlegel MK; Qian K; Sehgal A; Rajeev KG; Jadhav V; Manoharan M; Kuchimanchi S; Maier MA; Milstein S
    Mol Ther; 2018 Mar; 26(3):708-717. PubMed ID: 29456020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
    Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
    J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
    Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
    Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate.
    Zimmermann TS; Karsten V; Chan A; Chiesa J; Boyce M; Bettencourt BR; Hutabarat R; Nochur S; Vaishnaw A; Gollob J
    Mol Ther; 2017 Jan; 25(1):71-78. PubMed ID: 28129130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases.
    Li Q; Yin K; Ma HP; Liu HH; Li S; Luo X; Hu R; Zhang WW; Lv ZS; Niu XL; Gu MH; Li CL; Liu YS; Liu YJ; Li HB; Li N; Li C; Gu WW; Li JJ
    Mol Ther; 2024 Mar; 32(3):637-645. PubMed ID: 38204163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates.
    Brown CR; Gupta S; Qin J; Racie T; He G; Lentini S; Malone R; Yu M; Matsuda S; Shulga-Morskaya S; Nair AV; Theile CS; Schmidt K; Shahraz A; Goel V; Parmar RG; Zlatev I; Schlegel MK; Nair JK; Jayaraman M; Manoharan M; Brown D; Maier MA; Jadhav V
    Nucleic Acids Res; 2020 Dec; 48(21):11827-11844. PubMed ID: 32808038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of siRNA-mediated gene silencing in vivo.
    Zlatev I; Castoreno A; Brown CR; Qin J; Waldron S; Schlegel MK; Degaonkar R; Shulga-Morskaya S; Xu H; Gupta S; Matsuda S; Akinc A; Rajeev KG; Manoharan M; Maier MA; Jadhav V
    Nat Biotechnol; 2018 Jul; 36(6):509-511. PubMed ID: 29786096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways.
    Kandasamy P; Mori S; Matsuda S; Erande N; Datta D; Willoughby JLS; Taneja N; O'Shea J; Bisbe A; Manoharan RM; Yucius K; Nguyen T; Indrakanti R; Gupta S; Gilbert JA; Racie T; Chan A; Liu J; Hutabarat R; Nair JK; Charisse K; Maier MA; Rajeev KG; Egli M; Manoharan M
    J Med Chem; 2023 Feb; 66(4):2506-2523. PubMed ID: 36757090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Cluster and Monomer-Based GalNAc Structures Induce Effective Uptake of siRNAs in Vitro and in Vivo.
    Sharma VK; Osborn MF; Hassler MR; Echeverria D; Ly S; Ulashchik EA; Martynenko-Makaev YV; Shmanai VV; Zatsepin TS; Khvorova A; Watts JK
    Bioconjug Chem; 2018 Jul; 29(7):2478-2488. PubMed ID: 29898368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
    Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
    Springer AD; Dowdy SF
    Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
    McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
    Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Conjugated Multimeric siRNAs Enable Enhanced Uptake and Multiplexed Gene Silencing.
    Brown JM; Dahlman JE; Neuman KK; Prata CAH; Krampert MC; Hadwiger PM; Vornlocher HP
    Nucleic Acid Ther; 2019 Oct; 29(5):231-244. PubMed ID: 31393218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates.
    Parmar R; Willoughby JL; Liu J; Foster DJ; Brigham B; Theile CS; Charisse K; Akinc A; Guidry E; Pei Y; Strapps W; Cancilla M; Stanton MG; Rajeev KG; Sepp-Lorenzino L; Manoharan M; Meyers R; Maier MA; Jadhav V
    Chembiochem; 2016 Jun; 17(11):985-9. PubMed ID: 27121751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GalNAc bio-functionalization of nanoparticles assembled by electrostatic interactions improves siRNA targeting to the liver.
    Korin E; Bejerano T; Cohen S
    J Control Release; 2017 Nov; 266():310-320. PubMed ID: 28987883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of GalNAc-Oligonucleotide Conjugates Using GalNAc Phosphoramidite and Triple-GalNAc CPG Solid Support.
    Ulashchik EA; Martynenko-Makaev YV; Akhlamionok TP; Melnik DM; Shmanai VV; Zatsepin TS
    Methods Mol Biol; 2021; 2282():101-118. PubMed ID: 33928572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc-siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5'-exonuclease.
    Kumar P; Degaonkar R; Guenther DC; Abramov M; Schepers G; Capobianco M; Jiang Y; Harp J; Kaittanis C; Janas MM; Castoreno A; Zlatev I; Schlegel MK; Herdewijn P; Egli M; Manoharan M
    Nucleic Acids Res; 2020 May; 48(8):4028-4040. PubMed ID: 32170309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.